Free Trial
OTCMKTS:PVTTF

Pivotal Therapeutics (PVTTF) Stock Price, News & Analysis

Pivotal Therapeutics logo
$0.0018 0.00 (0.00%)
As of 05/12/2023

About Pivotal Therapeutics Stock (OTCMKTS:PVTTF)

Key Stats

Today's Range
$0.0018
$0.0018
50-Day Range
N/A
52-Week Range
$0.0018
$0.0018
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PVTTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pivotal Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PVTTF Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

PVTTF Stock Analysis - Frequently Asked Questions

Pivotal Therapeutics' stock was trading at $0.0018 at the beginning of 2025. Since then, PVTTF stock has increased by 0.0% and is now trading at $0.0018.

Shares of PVTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
N/A
Current Symbol
OTCMKTS:PVTTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
-0.41

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (OTCMKTS:PVTTF) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners